CSIMarket
 
Landec Corporation  (LNDC)
Other Ticker:  
 
 

Landec's Suppliers Performance

LNDC's Supply Chain

 
LNDC Costs vs Sales of Suppliers Growth Landec's Suppliers recorded increase in sales by 11.88 % year on year in Q3 2022, from the previous quarter, sales fell by -5.67 %, Landec's cost of sales deteriorated by % year on year, compare to one quarter ago cost of sales fell by -71.46 % in Q3.

More on LNDC Suppliers




Landec's Suppliers recorded increase in sales by 11.88 % year on year in Q3 2022, from the previous quarter, sales fell by -5.67 %, Landec's cost of sales deteriorated by -66.27 % year on year, compare to one quarter ago cost of sales fell by -71.46 % in Q3.

More on LNDC Suppliers




Landec's Comment on Supply Chain



Several of the raw materials used in manufacturing certain of the Company’s products are currently purchased from a single source. Although to date the Company has not experienced difficulty acquiring materials for the manufacture of its products, no assurance can be given that interruptions in supplies will not occur in the future, that the Company will be able to obtain substitute vendors, or that the Company will be able to procure comparable materials at similar prices and terms within a reasonable time. Any such interruption of supply could have a material adverse effect on the Company’s ability to manufacture and distribute its products and, consequently, could materially and adversely affect the Company’s business, operating results and financial condition.

Packaged Fresh Vegetables Business

The manufacturing process for the Company's proprietary BreatheWay packaging products is comprised of polymer manufacturing, membrane manufacturing and label package conversion. A third-party toll manufacturer currently makes virtually all of the polymers for the BreatheWay packaging system. Select outside contractors currently manufacture the breathable membranes, and Apio performs the label package conversion in its various processing facilities.

Apio processes a large majority of its packaged fresh vegetable products in its processing facility located in Guadalupe, California. Cooling of produce is done through third parties and Apio Cooling, LP, a separate consolidated subsidiary in which Apio has a 60% ownership interest and is the general partner.

Apio processes its fresh-cut, packaged green bean products in four processing plants located in Guadalupe, California; Bowling Green, Ohio; Hanover, Pennsylvania; and Vero Beach, Florida.

Biomaterials Business

The commercial production of HA by Lifecore requires fermentation, separation and purification and aseptic processing capabilities. Products are supplied in a variety of bulk and single dose configurations.


Lifecore produces its HA through a bacterial fermentation process. Medical grade HA was initially commercially available only through an extraction process from rooster combs. Lifecore believes that the fermentation manufacturing approach is superior to rooster comb extraction because of negativity surrounding animal-sourced materials, greater efficiency and flexibility, a more favorable long-term regulatory environment, and better economies of scale in producing large commercial quantities. Today’s HA competitors are primarily utilizing a fermentation process.

Lifecore’s facilities in Chaska, Minnesota are used primarily for the HA manufacturing process, formulation, aseptic syringe and bulk filling, secondary packaging, and warehousing raw materials and finished goods. The Company considers that the current inventory on-hand, together with its manufacturing capacity, will be sufficient to allow it to meet the needs of its current customers for the foreseeable future.

Lifecore provides versatility in the manufacturing of various types of finished products. It supplies several different forms of HA in a variety of molecular weight fractions as powders, solutions and gels, and in a variety of bulk and single-use finished packages. Lifecore continues to conduct development work designed to improve production efficiencies and expand its capabilities to achieve a wider range of HA product specifications in order to address the broadening opportunities for using HA in medical applications.

The FDA inspects the Company’s manufacturing systems periodically and requires compliance with the FDA’s Quality System Regulation (“QSR”) and its current Good Manufacturing Practices (“GMP”) regulations, as applicable. In addition, Lifecore’s customers conduct intensive quality audits of the facility and its operations. Lifecore also periodically contracts with independent regulatory consultants to conduct audits of its operations. Similar to other manufacturers subject to regulatory and customer specific requirements, Lifecore’s facility was designed to meet applicable regulatory requirements and has been cleared for the manufacturing of both device and pharmaceutical products. The Company maintains a Quality System which complies with applicable standards and regulations: FDA Medical Device Quality System requirements (21 CFR 820); FDA Drug Good Manufacturing Practices (21 CFR 210-211); European Union Good Manufacturing Practices (EudraLex Volume 4); Medical Device Quality Management System (ISO 13485); European Medical Device Directive; Canadian Medical Device Regulations; International Guide for Active Pharmaceutical Ingredients (ICH Q7), and Australian Therapeutic Goods Regulations). Compliance with these international standards of quality greatly assists in the marketing of Lifecore’s products globally.

Any disruptions in our primary manufacturing operations at Apio’s facilities in Guadalupe, CA, Bowling Green, OH or Hanover, PA or Lifecore’s facilities in Chaska, MN would reduce our ability to sell our products and would have a material adverse effect on our financial results. Additionally, we may need to consider seeking collaborative arrangements with other companies to manufacture our products. If we become dependent upon third parties for the manufacture of our products, our profit margins and our ability to develop and deliver those products on a timely basis may be adversely affected. In that event, additional regulatory inspections or approvals may be required, and additional quality control measures would need to be implemented. Failures by third parties may impair our ability to deliver products on a timely basis and impair our competitive position. We may not be able to continue to successfully operate our manufacturing operations at acceptable costs, with acceptable yields, and retain adequately trained personnel.

We may experience difficulty acquiring materials or services for the manufacture of our products or we may not be able to obtain substitute vendors. In addition, we may not be able to procure comparable materials at similar prices and terms within a reasonable time, if at all. Several services that are provided to Apio are obtained from a single provider. Several of the raw materials we use to manufacture our products are currently purchased from a single source, including some monomers used to synthesize Intelimer polymers, substrate materials for our breathable membrane products and raw materials for our HA products. Any interruption of our relationship with single-source suppliers or service providers could delay product shipments and materially harm our business.


Landec's Comment on Supply Chain



Several of the raw materials used in manufacturing certain of the Company’s products are currently purchased from a single source. Although to date the Company has not experienced difficulty acquiring materials for the manufacture of its products, no assurance can be given that interruptions in supplies will not occur in the future, that the Company will be able to obtain substitute vendors, or that the Company will be able to procure comparable materials at similar prices and terms within a reasonable time. Any such interruption of supply could have a material adverse effect on the Company’s ability to manufacture and distribute its products and, consequently, could materially and adversely affect the Company’s business, operating results and financial condition.

Packaged Fresh Vegetables Business

The manufacturing process for the Company's proprietary BreatheWay packaging products is comprised of polymer manufacturing, membrane manufacturing and label package conversion. A third-party toll manufacturer currently makes virtually all of the polymers for the BreatheWay packaging system. Select outside contractors currently manufacture the breathable membranes, and Apio performs the label package conversion in its various processing facilities.

Apio processes a large majority of its packaged fresh vegetable products in its processing facility located in Guadalupe, California. Cooling of produce is done through third parties and Apio Cooling, LP, a separate consolidated subsidiary in which Apio has a 60% ownership interest and is the general partner.

Apio processes its fresh-cut, packaged green bean products in four processing plants located in Guadalupe, California; Bowling Green, Ohio; Hanover, Pennsylvania; and Vero Beach, Florida.

Biomaterials Business

The commercial production of HA by Lifecore requires fermentation, separation and purification and aseptic processing capabilities. Products are supplied in a variety of bulk and single dose configurations.


Lifecore produces its HA through a bacterial fermentation process. Medical grade HA was initially commercially available only through an extraction process from rooster combs. Lifecore believes that the fermentation manufacturing approach is superior to rooster comb extraction because of negativity surrounding animal-sourced materials, greater efficiency and flexibility, a more favorable long-term regulatory environment, and better economies of scale in producing large commercial quantities. Today’s HA competitors are primarily utilizing a fermentation process.

Lifecore’s facilities in Chaska, Minnesota are used primarily for the HA manufacturing process, formulation, aseptic syringe and bulk filling, secondary packaging, and warehousing raw materials and finished goods. The Company considers that the current inventory on-hand, together with its manufacturing capacity, will be sufficient to allow it to meet the needs of its current customers for the foreseeable future.

Lifecore provides versatility in the manufacturing of various types of finished products. It supplies several different forms of HA in a variety of molecular weight fractions as powders, solutions and gels, and in a variety of bulk and single-use finished packages. Lifecore continues to conduct development work designed to improve production efficiencies and expand its capabilities to achieve a wider range of HA product specifications in order to address the broadening opportunities for using HA in medical applications.

The FDA inspects the Company’s manufacturing systems periodically and requires compliance with the FDA’s Quality System Regulation (“QSR”) and its current Good Manufacturing Practices (“GMP”) regulations, as applicable. In addition, Lifecore’s customers conduct intensive quality audits of the facility and its operations. Lifecore also periodically contracts with independent regulatory consultants to conduct audits of its operations. Similar to other manufacturers subject to regulatory and customer specific requirements, Lifecore’s facility was designed to meet applicable regulatory requirements and has been cleared for the manufacturing of both device and pharmaceutical products. The Company maintains a Quality System which complies with applicable standards and regulations: FDA Medical Device Quality System requirements (21 CFR 820); FDA Drug Good Manufacturing Practices (21 CFR 210-211); European Union Good Manufacturing Practices (EudraLex Volume 4); Medical Device Quality Management System (ISO 13485); European Medical Device Directive; Canadian Medical Device Regulations; International Guide for Active Pharmaceutical Ingredients (ICH Q7), and Australian Therapeutic Goods Regulations). Compliance with these international standards of quality greatly assists in the marketing of Lifecore’s products globally.

Any disruptions in our primary manufacturing operations at Apio’s facilities in Guadalupe, CA, Bowling Green, OH or Hanover, PA or Lifecore’s facilities in Chaska, MN would reduce our ability to sell our products and would have a material adverse effect on our financial results. Additionally, we may need to consider seeking collaborative arrangements with other companies to manufacture our products. If we become dependent upon third parties for the manufacture of our products, our profit margins and our ability to develop and deliver those products on a timely basis may be adversely affected. In that event, additional regulatory inspections or approvals may be required, and additional quality control measures would need to be implemented. Failures by third parties may impair our ability to deliver products on a timely basis and impair our competitive position. We may not be able to continue to successfully operate our manufacturing operations at acceptable costs, with acceptable yields, and retain adequately trained personnel.

We may experience difficulty acquiring materials or services for the manufacture of our products or we may not be able to obtain substitute vendors. In addition, we may not be able to procure comparable materials at similar prices and terms within a reasonable time, if at all. Several services that are provided to Apio are obtained from a single provider. Several of the raw materials we use to manufacture our products are currently purchased from a single source, including some monomers used to synthesize Intelimer polymers, substrate materials for our breathable membrane products and raw materials for our HA products. Any interruption of our relationship with single-source suppliers or service providers could delay product shipments and materially harm our business.



LNDC's Suppliers Net Income grew by LNDC's Suppliers Net margin fell in Q3 to
9.42 % 9.57 %


Landec Corporation's Suppliers Sales Growth in Q3 2022 by Industry

Suppliers in Chemical Manufacturing Industry      7.43 %
Suppliers in Chemicals - Plastics & Rubber Industry -8.33 %   
Suppliers in Containers & Packaging Industry      45.82 %
Suppliers in Miscellaneous Fabricated Products Industry  
Suppliers in Paper & Paper Products Industry -8.08 %   
Suppliers in Construction Raw Materials Industry      56.3 %
Suppliers in Construction Services Industry      8.21 %
Suppliers in Miscellaneous Manufacturing Industry      0.34 %
Suppliers in Conglomerates Industry      5.64 %
Suppliers in Nonalcoholic Beverages Industry      2.98 %
Suppliers in Agricultural Production Industry      25.03 %
Suppliers in Food Processing Industry      6.45 %
Suppliers in Tobacco Industry      28.22 %
Suppliers in Oil & Gas Integrated Operations Industry      43.34 %
Suppliers in Investment Services Industry      10.62 %
Suppliers in Blank Checks Industry  
Suppliers in Biotechnology & Pharmaceuticals Industry  
Suppliers in Medical Equipment & Supplies Industry -3.61 %   
Suppliers in Professional Services Industry      14.94 %
Suppliers in Computer Peripherals & Office Equipment Industry      12.8 %
Suppliers in Electronic Instruments & Controls Industry      6 %
Suppliers in Transport & Logistics Industry -19.67 %   
Suppliers in Railroads Industry      18.32 %
     
• LNDC Suppliers Valuation • LNDC Segment Rev. Growth • LNDC Segment Inc. Growth • LNDC Suppliers Mgmt. Effect.





LNDC's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Landec Corporation 259.09 363.42 -160.79 522
Seaboard Corporation 4,632.01 10,065.00 538.00 10,772
3m Company 71,039.10 34,762.00 6,588.00 95,000
Ball Corp 17,232.27 15,475.00 973.00 0
Bemis Co Inc 5,239.24 4,063.90 238.50 19,100
Conagra Brands Inc. 18,527.34 12,286.70 575.00 16,500
Csx Corporation 66,650.10 14,550.00 4,082.00 19,300
Dupont De Nemours Inc 35,238.17 14,184.00 1,905.00 34,250
Honeywell International Inc 146,759.30 34,937.00 5,388.00 105,500
Illinois Tool Works Inc 69,431.64 15,640.00 2,736.00 44,000
International Paper Company 13,161.81 22,292.00 2,686.00 51,000
Jacobs Solutions Inc 15,762.14 14,922.83 715.41 55,000
Monument Circle Acquisition Corp 250.50 14,593.00 11.96 22,500
ROHM AND HAAS COMPANY 0.00 0.00 0.00 0
Sealed Air Corp 7,812.31 5,767.50 578.20 16,500
Waters Corp 25,639.15 -1,134.84 593.79 7,500
Cf Industries Holdings inc 20,789.13 11,118.00 3,787.00 3,000
O i Glass Inc 2,574.75 6,751.00 662.00 21,100
Fmc Corporation 16,650.87 5,593.90 648.30 6,400
Ecolab Inc 43,073.84 13,881.20 1,144.70 50,200
Mosaic Co 16,755.66 18,484.90 -793.70 13,300
Accenture Plc 187,975.95 61,594.31 6,884.52 510,500
Mccormick and Co Inc 22,710.31 6,385.10 693.70 13,000
Marten Transport Ltd 1,647.76 1,208.17 109.57 3,240
Heartland Express Inc 1,290.19 639.85 72.97 4,500
Brady Corp 2,371.76 1,303.16 154.37 6,560
Wayne Savings Bancshares Inc 71.99 13.06 2.50 104
Wells Financial Corp 0.00 0.00 0.00 76
Viscount Systems Inc 0.00 0.00 0.00 36
Darling Ingredients Inc 9,975.41 5,442.25 696.17 10,000
Ingredion Incorporated 6,627.37 7,714.00 455.00 1,100
Sanfilippo John B and Son Inc 956.48 982.14 58.08 1,350
Snyders-lance, Inc. 3,534.89 1,774.31 68.98 5,000
Treehouse Foods Inc 2,748.90 4,379.50 -152.00 5,880
Kraft Heinz Co 48,902.40 25,813.00 1,226.00 37,000
Omega Protein Corp 493.88 342.36 18.67 627
Eastman Chemical Co 10,532.55 10,901.00 1,174.00 14,500
Archer daniels midland Co 51,103.51 98,707.00 4,138.00 38,100
Planet Green Holdings Corp 43.36 59.96 -9.99 0
Cme Group Inc 64,808.37 4,958.90 6,032.60 4,360
General Mills Inc. 52,419.26 19,170.50 2,920.10 35,000
Bunge Limited 14,241.61 67,255.00 1,536.00 33,000
Ricebran Technologies 5.92 39.04 -11.58 264
J and j Snack Foods Corp 3,060.67 1,380.66 47.24 2,300
Zivo Bioscience Inc 25.72 0.00 -9.62 2
Agritech Worldwide, Inc. 0.00 0.00 0.00 14
Rayont Inc. 4.81 2.78 -0.39 4
Cal maine Foods Inc. 2,877.41 2,103.80 275.60 3,277
China Green Agriculture Inc 64.65 158.67 -83.82 17
Chs Inc 0.00 47,791.67 1,677.90 0
Golden Growers Cooperative 65.70 102.88 7.13 1
Kiwa Bio-tech Products Group Corp 0.01 39.18 -0.92 1
Royal Hawaiian Orchards, L.p. 86,961.54 29.13 4.55 262
Thermo Fisher Scientific Inc 221,769.58 39,982.00 6,889.00 75,000
Clearwater Paper Corporation 653.81 2,043.20 176.60 3,300
Kapstone Paper & Packaging Corp 3,496.53 3,439.03 303.66 6,400
Mativ Holdings Inc. 655.84 1,594.60 27.40 0
Best Inc 261.55 1,792.96 32.90 393
Crown Holdings Inc 9,894.02 12,224.00 -341.00 24,000
Graphic Packaging Holding Co 6,994.69 9,042.00 405.00 13,000
Packaging Corp Of America 12,710.63 8,542.70 1,034.80 15,500
Silgan Holdings Inc 5,944.58 6,395.38 401.29 6,700
Sonoco Products Company 5,984.54 6,127.35 -32.50 20,000
Compass Minerals International Inc. 1,524.98 554.70 39.50 3,103
Intrepid Potash inc 464.43 292.59 292.10 494
I minerals Inc. 1.42 0.00 -1.42 5
Li3 Energy, Inc. 9.24 0.00 -45.36 2
Trident Brands Incorporated 0.00 0.21 -0.49 1
American Vanguard Corporation 674.19 608.45 28.38 395
Balchem Corporation 4,249.28 922.96 108.91 1,060
Bioamber Inc. 0.67 14.94 -102.19 86
The Chemours Company 4,855.26 7,030.00 907.00 7,000
Huntsman Corporation 5,621.42 9,069.00 1,204.00 15,000
Hawkins Inc 866.99 768.68 102.01 659
Innophos Holdings Inc 632.66 766.13 28.89 1,319
Kraton corp 1,522.04 1,970.13 175.59 1,971
Quaker Chemical Corporation 3,301.28 1,905.82 78.23 2,020
Lsb Industries Inc 1,127.49 858.29 206.71 610
Marrone Bio Innovations Inc 145.46 44.37 -20.89 97
Muliang Viagoo Technology Inc 207.92 10.25 1.25 1
Momentive Performance Materials Inc. 1,560.49 2,331.00 0.00 4,900
Anheuser busch Inbev Sa 121,768.20 54,304.00 6,114.00 0
Dow Inc 36,802.63 59,407.00 5,754.00 35,700
Lyondellbasell Industries N v 83.47 53,075.00 4,262.00 19,100
Danaher Corporation 197,601.08 31,250.00 6,765.00 60,000
Integral Technologies Inc 2.90 1.08 -5.69 1
Cabot Corporation 4,234.85 4,321.00 243.00 4,300
Celanese Corporation 11,820.57 9,600.00 1,659.00 7,658
Gevo Inc 466.20 0.68 -89.13 74
W R Grace and co 4,647.34 1,859.20 79.90 3,700
Innospec Inc 2,719.19 1,866.20 131.40 1,800
Newmarket Corporation 3,195.11 2,658.81 206.22 1,998
Ingevity Corporation 2,878.53 1,620.70 225.30 1,500
Nl Industries inc 334.88 160.67 57.24 2,776
Oci Partners Lp 986.20 367.78 40.88 122
Element Solutions Inc 3,242.74 1,961.00 -319.90 7,750
Arcadia Biosciences Inc 8.30 11.13 -20.84 47
Stepan Company 2,564.38 2,756.12 153.38 2,073
American Soil Technologies Inc 0.00 0.00 0.00 3
Sensient Technologies Corp 3,153.79 1,428.75 139.00 4,083
Univar Solutions Inc 5,632.97 11,380.80 894.00 8,700
Westlake Corporation 13,822.28 16,002.00 2,710.00 8,870
Westlake Chemical Partners Lp 795.12 1,618.76 356.19 141
Advansix Inc 1,168.59 1,968.59 161.85 1,340
Aptargroup inc 7,104.19 3,340.33 237.69 12,700
Berry Global Group Inc 8,078.18 14,149.00 780.00 21,000
Avient Corporation 3,147.87 4,621.00 187.40 0
Schulman A Inc 1,306.23 2,693.61 35.59 4,800
Trinseo Plc 836.00 5,259.60 27.40 2,197
Vystar Corporation 3.24 15.60 -4.21 1
Greif Inc 1,862.87 6,300.60 373.60 0
Tredegar Corporation 350.56 999.02 38.53 2,800
Unifi Inc 155.97 761.37 15.19 3,000
Cvr Energy Inc 3,339.62 13,575.00 541.00 968
Trecora Resources 231.52 301.32 8.99 310
SUBTOTAL 1,912,218.17 1,066,490.87 104,699.83 1,743,525
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EGY's Profile

Stock Price

EGY's Financials

Business Description

Fundamentals

Charts & Quotes

EGY's News

Suppliers

EGY's Competitors

Customers & Markets

Economic Indicators

EGY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071